ArticleBiometrics2025
Large row-constrained supersaturated designs for high-throughput screening.
Article in Biometrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
High-throughput screening, in which large numbers of compounds are traditionally studied one-at-a-time in multiwell plates against specific targets, is widely used across many areas of the biological sciences, including drug discovery. To improve the effectiveness of these screens, we propose a new class of supersaturated designs that guide the construction of pools of compounds in each well. Because the size of the pools is typically limited by the particular application, the new designs accommodate this constraint and are part of a larger procedure that we call Constrained Row Screening or CRowS. We develop an efficient computational procedure to construct the CRowS designs, provide some initial lower bounds on the average squared off-diagonal values of their main-effects information matrix, and study the impact of the constraint on design quality. We also show via simulation that CRowS is statistically superior to the traditional one-compound-one-well approach as well as an existing pooling method, and demonstrate the use of the new methodology on a Verona Integron-encoded Metallo-$\beta$-lactamase-2 assay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.